Inspection for Particulate Matter Essential to I.V. Additive Program

Abstract

Get full access to this article

View all access options for this article.

References

Krueger

Elmer

Riggs

Thomas

: PMA Parenteral Particulate Matter Committee, Bull. Parenteral Drug Assoc. 22: 99–103 (Mar.-Apr.) 1968.

Norman

: Particulate Matter in Parenteral Solutions, Drug Intelligence 1: 7–11 (Jan.) 1967.

Gross

Adrian

: Danger of Particulate Matter in Solutions for Intravenous Use, Drug Intelligence 1: 12–13 (Jan.) 1967.

Garvan

J. M.

Gunner

B. W.

: Harmful Effects of Particles in Intravenous Fluids, Med. J. Australia 2: 1–6 (July 4) 1963.

Garvan

J. M.

Gunner

B. W.

: Intravenous Fluids: A Solution Containing Such Particles Must Not Be Used, ibid. 2: 140–145 (July 27) 1963.

Yakowitz

Morris

: Problems Associated with the Manufacture, Storage, and Use of Large Volume Parenteral Solutions, Safety of Large Volume Parenteral Solutions, p. 5 (July 28–29) 1966.

Garvan

J. M.

Gunner

B. W.

: Harmful Effects of Particles in Intravenous Fluids, Med. J. Australia 2: 1–6 (July 4) 1963.

Von Glahn

W. C.

Hall

J. W.

: Reaction Produced in the Pulmonary Arteries by Emboli of Cotton Fibers, Am. J. Pathol. 25: 575–595 (July) 1949.

Stehbens

W. E.

Florey

H. W.

: Behavior of Intravenously Injected Particles Observed in Chambers in Rabbits' Ears, Quart. J. Exptl. Physiol. 45: 252–264 (July) 1960.

10.

Brewer

John H.

Dunning

J. H.

: An in Vitro and in Vivo Study of Glass Particles in Ampuls, J. Am. Pharm. Assoc. 36: 289–293 (Aug.) 1947.

11.

Griffin

G. D.

Essex

H. E.

Mann

F. C.

: Experimental Evidence Concerning Death from Small Pulmonary Emboli, Surg. Gynecol. Obstet. 92: 313–318 (Apr.) 1951.

12.

Norman

: Particulate Matter in Parenteral Solutions, Drug Intelligence 1: 7–11 (Jan.) 1967.

13.

Groves

M. J.

: Harmful Effects of Parenteral Solutions. Methods for Their Detection, J. Hosp. Pharm. 25: 17 (Jan.) 1968.

14.

Endicott

C. J.

Giles

Pecina

: Particulate Matter—Its Significance, Source, Measurement and Elimination, Safety of Large Volume Parenteral Solutions, p. 63 (July 28–29) 1966.

15.

Anon.: Particulate Matter in Parenteral Solutions, Med. Letter 10: 44 (May 31) 1968.

16.

United State Pharmacopeia Convention, United States Pharmacopeia, Eighteenth Revision, Mack Printing Company, Easton, Pa., 1970, p. 924.

17.

Hoover

John E.

: Remington's Pharmaceutical Sciences, Mack Printing Company, Easton, Pa., 1970, p. 1525.

18.

Kramer

Warren

: Precipitates Found in Admixtures of Potassium Chloride and Dextrose 5% in Water, Am. J. Hosp. Pharm. 27: 548–553 (July) 1970.

19.

Lachman

Leon

: Stability of Antibacterial Preservatives in Parenteral Solutions IV, J. Pharm. Sci. 52: 244 (Mar.) 1963.

20.

Lachman

Leon

: Contribution of Rubber Closures to Particulate Matter in Large Volume Parenteral Solutions, Safety of Large Volume Parenteral Solutions, p. 53 (July 28–29) 1966.

21.

Vessey

Kendal

: Determination of Particulate Matter in Intravenous Fluids, Analyst 91: 273–279 (Apr.) 1966.

22.

Anon.: Particulate Matter in Parenteral Solutions, Med. Letter 10: 43 (May 31) 1968.

23.

Ernerot

Dahlinder

: Contamination of Ampoules in Connection with Opening, Acta Pharm. Suec. 6: 401–406 (June) 1969.

24.

Charlebois

Peter

: Coring: The Unseen Menace, Can. Anaes. Soc. J. 13: 595 (Nov.) 1966.

25.

Loughhead

Harold

: Training of Clean Room Personnel, Bull. Parenteral Drug Assoc. 23: 228–232 (Sept.-Oct.) 1969.

26.

United States Pharmacopeia Convention, United States Pharmacopeia, Eighteenth Revision, Mack Printing Company, Easton, Pa., 1970, p. 797.